AB
Aytu BioScience Inc
🇺🇸XNAS.AYTUUnited StatesHealthcare
$1.96USDdown -0.04 (-2%)After-hoursDelayed8:08 PM
Price$1.96-0.04 (-2%)
Profile
- Healthcare
- Drug Manufacturers - Specialty & Generic
- United States
Identity
- Exchange
- Nasdaq . XNAS
- Type
- Stock
- ISIN
- US0547548588
- CUSIP
- 054754205
Company
- Employees
- 82
- Headquarters
- Denver, United States
- Website
- https://aytubio.com
- CEO
- Mr. Joshua R. Disbrow
Market
- Shares outstanding
- 10.7M
- Market cap
- $21.04M
Key dates
- Next earnings
- Sep 22, 2026
Highlights
No high and low reported for today's session.
- Market cap
- $21.57M
- EPS LTM
- -$3.17calculatedCalculated by Finzer, not reported by the data provider.
- P/E LTM
- -0.62calculatedCalculated by Finzer, not reported by the data provider.
- Div yield
- Not reported
Fundamentals (LTM)
- Revenue
- $56.6M-18.24%down year on year
- Net income
- -$34.06M-2,177.79%down year on year
- Gross margin
- 62.5%-8.88%down year on year
- Free cash flow
- $1.64M+127.09%up year on year
Other listings
This company is not listed on any other exchange we cover.
These are the venues Finzer covers, not every venue that exists.
Business summary
No company summary reported yet.